Introduction {#S0001}
============

According to the latest International Society for the Study of Vascular Anomalies, classification cerebral cavernous malformations, also referred to as cavernomas, cavernous hemangiomas or cavernous angiomas are defined as simple vascular malformations in the subgroup of venous malformations.[@CIT0001] They are present in approximately 0.5% of the population while most of them remain asymptomatic. Cavernomas found in the central nervous system may cause headaches, seizures, stroke, hydrocephalus or focal neurological symptoms. Cavernomas are usually small (2 mm to few centimeters) and are composed of thin-walled, dilated capillaries that lack elastic fibers and smooth muscles.[@CIT0002] Most lesions are considered to be congenital; however, they can also form sporadically or de novo after brain surgery or radiotherapy.[@CIT0003] Three gene mutations associated with the formation of cavernomas have been reported (CCM1, CCM2 and CCM3).[@CIT0004]

While asymptomatic cavernomas are usually observed, symptomatic lesions should be removed by microsurgical resection, if the lesions are surgically accessible.[@CIT0005] Symptomatic lesions which are not surgically accessible may be treated with stereotactic radiosurgery. Despite the fact that radiation decreases the risk of bleeding, radiation-induced permanent neurological defects are considerably higher in this patient group.[@CIT0006] More recent studies showed better long-term neurological outcome in patients after radiosurgery, compared to the natural course with cumulative morbidity due to repeated hemorrhages.[@CIT0007],[@CIT0008] Of note, recent reports suggest a positive effect on recurrent bleeding and development of new lesions for propranolol.[@CIT0009]

Intraventricular cavernous malformations are a rare subgroup. They constitute 2.5--10.8% of all cerebral cavernomas.[@CIT0010] Intraventricular cavernomas reportedly have a higher tendency for bleeding and re-bleeding, which may result in the development of an obstructive hydrocephalus. Due to their anatomical position, intraventricular cavernomas are suitable for endoscopic surgery, though the risk of intraoperative bleeding has to be considered, eventually obstructing the endoscopic view and necessitating a switch to open microscopic neurosurgery.

Case report {#S0002}
===========

We present the case of a 48-year-old woman with a known cerebral cavernomatosis combined with epilepsy. It is known that her mother was diagnosed with cerebral cavernous malformation as an incidental finding in a cranial MR imaging, yet our patient refused genetic testing. She suffers from multiple cerebral cavernous malformations (more than 15) and underwent microsurgical removal of symptomatic lesions four times in the course of the last 18 years. Three of these were located in the left hemisphere, the fourth one had provoked a left-sided cerebellar hemorrhage 12 years ago. A hysterectomy for hypermenorrhagia was performed 4 years ago. The patient receives levothyroxine substitution and lamotrigine. Although advised otherwise, she continues to smoke cigarettes.

In follow-up cranial MR imaging, a cavernous malformation located in the right lateral ventricle had occurred about two years ago and demonstrated not only an increasing size but also microbleeding ([Figure 1](#F0001){ref-type="fig"}, upper row). The proposition was made to remove this lesion endoscopically via a frontal burr hole guided by neuronavigation to spare the patient a fifth trepanation.Figure 1Upper row, transaxial cranial MR T2 weighted images demonstrating intraventricular cavernous malformation in the right lateral ventricle (white arrow). Note the increase in size over the course of 13 months. Upper row image to the right, transaxial cranial MR susceptibility-weighted image with microbleeding of the lesion. Lower row, coronal cranial MR T1-weighted and contrast-enhanced image demonstrating the cavernous malformation adjacent to the floor of the right lateral ventricle (short white arrow). The postoperative image demonstrates the total resection of the lesion. Note the small defect in the surrounding brain parenchyma caused by the endoscopic approach (arrowhead).

The patient remained reluctant and, only after a further 6-month MRI control depicting a still increasing size of the intraventricular cavernoma, finally consented to the neurosurgical intervention. The operation and postoperative period were uneventful. Histologic examination showed an atypical dilatated blood vessel with signs of recurrent hemorrhage, in the given clinical context compatible with parts of a cavernous hemangioma. Postoperative MR imaging demonstrated a complete resection ([Figure 1](#F0001){ref-type="fig"}, lower row). The patient could be discharged 4 days after surgery. Neurologic examination revealed right-sided sensibility loss and gait disturbances as sequelae of the former four neurosurgical interventions. The symptoms remained unchanged after the endoscopy, without the occurrence of further deficits or an epileptic seizure. Postsurgery wound pain relieved quickly. Noteworthily, neither the de novo occurrence of the cavernous malformation nor the microbleeding caused any new neurological symptoms.

Total operation time was 2 hrs 18 mins including the positioning of the patient in supine position, setting up the neuronavigation and the endoscope. The time needed for resection (skin to skin) of the lesion was 1 hr 15 mins. For surgical access, Kocher's point was chosen. A small, approx. 3-cm-long incision was made and a single burr hole with a diameter of 1 cm was placed. The dura was opened with a small incision and the endoscope was carefully advanced toward the lesion following the trajectory of the neuronavigation. Video 1 gives an impression of the endoscopic view, displaying the use of electrocautery to coagulate the attachment of the cavernoma to the lateral thalamic wall and the use of the forceps to remove the lesion in one piece by seizing the thinned and coagulated stalk.

Written informed consent has been provided by the patient to have the case details and any accompanying images published. No institutional approval was required to publish this case report.

Discussion {#S0003}
==========

In our limited experience with endoscopic resection of cavernous malformation, we can report that this operation method represents a good alternative to open surgery in selected cases. The surgical access is considerably smaller, causing less trauma to the surrounding brain tissue and the total operation time is notably shorter. There is no craniotomy needed, a simple burr hole is sufficient. We can, therefore, confirm the findings of Gianetti et al, Palandri et al and Prat et al, who had reported successful endoscopic resection of intraventricular cavernous malformations.[@CIT0011]--[@CIT0013]

However, it must be noted that intraoperative complications, especially bleeding, are more difficult to control, as not only the freedom of movement is very limited in endoscopical procedures but also the view can more easily be blocked. Patients should therefore carefully be selected considering the position and the size of the cavernoma, and adequate preoperative planning including possible switching to an open access has to be performed.

The endoscopic approach is limited to intraventricular cavernous malformations, as intraparenchymal lesions are not accessible with this technique. Although technical advantages have been made in recent years, endoscopic neurosurgical approaches still require preformed cavities as the ventricular system or large cysts found in complex hydrocephalus.[@CIT0014] In our opinion, endoscopic resection should at least be considered as a surgical approach for intraventricular cavernous malformations within the lateral ventricles, the interventricular foramina and to some extent the third ventricle. It should be noted that large lesions may be difficult to handle as they more easily block the view of the endoscope.
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